Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness.

AIDS (London, England) - 9 Jan 2006

Bangsberg David R, Acosta Edward P, Gupta Reena, Guzman David, Riley Elise D, Harrigan P Richard, Parkin Neil, Deeks Steven G

Abstract excerpt

OBJECTIVE: To compare the prevalence of resistance by adherence level in patients treated with non-nucleoside reverse transcriptase inhibitors (NNRTI) or protease inhibitors (PI). Also to examine the mechanism of differential class-specific adherence-resistance relationships, focusing on the patient-derived capacity of wild-type and drug-resistant recombinant variants to replicate in vitro in the presence of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to HIV Protease Inhibitors

Share to HIV Reverse Transcriptase

Share to Patient Compliance

Share to Reverse Transcriptase Inhibitors

Share to Viral Load

Source

Identifiers

PMID: 16511415
DOI: 10.1097/01.aids.0000199825.34241.49

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness.PMID 16511415Read ↗

Antiretroviral medication adherence and the development of class-specific antiretroviral resistanceSemantic proximity Read ↗

Modeling the HIV Protease Inhibitor Adherence–Resistance Curve by Use of Empirically Derived EstimatesSemantic proximity Read ↗

Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study.Semantic proximity Read ↗

Antiretroviral dynamics determines HIV evolution and predicts therapy outcome.Semantic proximity Read ↗

Assessing the impact of adherence to anti-retroviral therapy on treatment failure and resistance evolution in HIV.Semantic proximity Read ↗

Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patients.Semantic proximity Read ↗

Adherence and drug resistance: predictions for therapy outcomeSemantic proximity Read ↗

Genotypic resistance and immunologic outcomes among HIV-1-infected women with viral failure.Semantic proximity Read ↗

The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classes.Semantic proximity Read ↗

The HIV-1 integrase genotype strongly predicts raltegravir susceptibility but not viral fitness of primary virus isolates.Semantic proximity Read ↗

Nonnucleoside Reverse Transcriptase Inhibitor ResistanceSemantic proximity Read ↗

Nonnucleoside Reverse Transcriptase Inhibitor ResistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.